Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 94 entries
Sorted by: Best Match Show Resources per page
[Can present-day instruction in chemistry satisfy the requirements for the health care professions?].

Deutsche Schwesternzeitung

Heyke HE.
PMID: 5202188
Dtsch Schwesternztg. 1970 Sep;23(9):460-1.

No abstract available.

Cite
Heyke HE. Kann die heutige Chemieausbildung den Anforderungen in den medizinischen Berufen noch genügen? [Can present-day instruction in chemistry satisfy the requirements for the health care professions?]. Dtsch Schwesternztg. 1970;23(9):460-1
Heyke, H. E. (1970). Kann die heutige Chemieausbildung den Anforderungen in den medizinischen Berufen noch genügen? [Can present-day instruction in chemistry satisfy the requirements for the health care professions?]. Deutsche Schwesternzeitung, 23(9), 460-1.
Heyke, H E. "Kann die heutige Chemieausbildung den Anforderungen in den medizinischen Berufen noch genügen?" [Can present-day instruction in chemistry satisfy the requirements for the health care professions?]. Deutsche Schwesternzeitung vol. 23,9 (1970): 460-1.
Heyke HE. Kann die heutige Chemieausbildung den Anforderungen in den medizinischen Berufen noch genügen? [Can present-day instruction in chemistry satisfy the requirements for the health care professions?]. Dtsch Schwesternztg. 1970 Sep;23(9):460-1. German. PMID: 5202188.
Copy Download .nbib Format: NLM
Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome.

PloS one

Powell NM, Modat M, Cardoso MJ, Ma D, Holmes HE, Yu Y, O'Callaghan J, Cleary JO, Sinclair B, Wiseman FK, Tybulewicz VL, Fisher EM, Lythgoe MF, Ourselin S.
PMID: 27658297
PLoS One. 2016 Sep 22;11(9):e0162974. doi: 10.1371/journal.pone.0162974. eCollection 2016.

We describe a fully automated pipeline for the morphometric phenotyping of mouse brains from μMRI data, and show its application to the Tc1 mouse model of Down syndrome, to identify new morphological phenotypes in the brain of this first...

Cite
Powell NM, Modat M, Cardoso MJ, et al. Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome. PLoS One. 2016;11(9):e0162974doi: 10.1371/journal.pone.0162974.
Powell, N. M., Modat, M., Cardoso, M. J., Ma, D., Holmes, H. E., Yu, Y., O'Callaghan, J., Cleary, J. O., Sinclair, B., Wiseman, F. K., Tybulewicz, V. L., Fisher, E. M., Lythgoe, M. F., & Ourselin, S. (2016). Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome. PloS one, 11(9), e0162974. https://doi.org/10.1371/journal.pone.0162974
Powell, Nick M, et al. "Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome." PloS one vol. 11,9 (2016): e0162974. doi: https://doi.org/10.1371/journal.pone.0162974
Powell NM, Modat M, Cardoso MJ, Ma D, Holmes HE, Yu Y, O'Callaghan J, Cleary JO, Sinclair B, Wiseman FK, Tybulewicz VL, Fisher EM, Lythgoe MF, Ourselin S. Fully-Automated μMRI Morphometric Phenotyping of the Tc1 Mouse Model of Down Syndrome. PLoS One. 2016 Sep 22;11(9):e0162974. doi: 10.1371/journal.pone.0162974. eCollection 2016. PMID: 27658297; PMCID: PMC5033246.
Copy Download .nbib Format: NLM
Morphogenesis: Re: Clinical, natural history, and imaging information on patients included in reports.

American journal of medical genetics. Part A

Aylsworth A, Graham JM, Hall JG, Hoyme HE, Jones KL, Stevenson RE.
PMID: 12707969
Am J Med Genet A. 2003 May 15;119(1):93; discussion 94. doi: 10.1002/ajmg.a.10185.

No abstract available.

Cite
Aylsworth A, Graham JM, Hall JG, et al. Morphogenesis: Re: Clinical, natural history, and imaging information on patients included in reports. Am J Med Genet A. 2003;119(1):93; discussion 94doi: 10.1002/ajmg.a.10185.
Aylsworth, A., Graham, J. M., Hall, J. G., Hoyme, H. E., Jones, K. L., & Stevenson, R. E. (2003). Morphogenesis: Re: Clinical, natural history, and imaging information on patients included in reports. American journal of medical genetics. Part A, 119(1), 93; discussion 94. https://doi.org/10.1002/ajmg.a.10185
Aylsworth, Art, et al. "Morphogenesis: Re: Clinical, natural history, and imaging information on patients included in reports." American journal of medical genetics. Part A vol. 119,1 (2003): 93; discussion 94. doi: https://doi.org/10.1002/ajmg.a.10185
Aylsworth A, Graham JM, Hall JG, Hoyme HE, Jones KL, Stevenson RE. Morphogenesis: Re: Clinical, natural history, and imaging information on patients included in reports. Am J Med Genet A. 2003 May 15;119(1):93; discussion 94. doi: 10.1002/ajmg.a.10185. PMID: 12707969.
Copy Download .nbib Format: NLM
The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies.

Iranian journal of allergy, asthma, and immunology

Afshari A, Holme RE.
PMID: 17301402
Iran J Allergy Asthma Immunol. 2004 Sep;3(3):121-5. doi: 03.03/ijaai.121125.

The measurement of anti-streptokinase antibodies can distinguish the patients who may benefit from streptokinase and those who should be treated with some other thrombolytic regimen. Neutralising titration test is a commonly used classical assay for measuring anti-streptokinase antibodies and...

Cite
Afshari A, Holme RE. The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies. Iran J Allergy Asthma Immunol. 2004;3(3):121-5doi: 03.03/ijaai.121125.
Afshari, A., & Holme, R. E. (2004). The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies. Iranian journal of allergy, asthma, and immunology, 3(3), 121-5. https://doi.org/03.03/ijaai.121125
Afshari, Afshin, and Holme, R Elizbeth. "The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies." Iranian journal of allergy, asthma, and immunology vol. 3,3 (2004): 121-5. doi: https://doi.org/03.03/ijaai.121125
Afshari A, Holme RE. The Effect of Recombinant Tissue Plasminogen Activator (r-tPA) on Quantitation of Neutralising Anti-Streptokinase Antibodies. Iran J Allergy Asthma Immunol. 2004 Sep;3(3):121-5. doi: 03.03/ijaai.121125. PMID: 17301402.
Copy Download .nbib Format: NLM
Letter by Jenner and Portraits of Francis Home, of Edinburgh (1719-1813).

Proceedings of the Royal Society of Medicine

Home WE.
PMID: 19985659
Proc R Soc Med. 1927 Mar;20(5):584-5.

No abstract available.

Cite
Home WE. Letter by Jenner and Portraits of Francis Home, of Edinburgh (1719-1813). Proc R Soc Med. 1927;20(5):584-5
Home, W. E. (1927). Letter by Jenner and Portraits of Francis Home, of Edinburgh (1719-1813). Proceedings of the Royal Society of Medicine, 20(5), 584-5.
Home, W E. "Letter by Jenner and Portraits of Francis Home, of Edinburgh (1719-1813)." Proceedings of the Royal Society of Medicine vol. 20,5 (1927): 584-5.
Home WE. Letter by Jenner and Portraits of Francis Home, of Edinburgh (1719-1813). Proc R Soc Med. 1927 Mar;20(5):584-5. PMID: 19985659; PMCID: PMC2101132.
Copy Download .nbib Format: NLM
Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Bégin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Tavassoli M, Hoyte E, O'Riordan G, Blakemore A, Seki S, Hamilton RG, Nadeau KC.
PMID: 24576338
Allergy Asthma Clin Immunol. 2014 Feb 20;10(1):7. doi: 10.1186/1710-1492-10-7.

BACKGROUND: Up to 30% of patients with food allergies have clinical reactivity to more than one food allergen. Although there is currently no cure, oral immunotherapy (OIT) is under investigation. Pilot data have shown that omalizumab may hasten the...

Cite
Bégin P, Dominguez T, Wilson SP, et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol. 2014;10(1):7doi: 10.1186/1710-1492-10-7.
Bégin, P., Dominguez, T., Wilson, S. P., Bacal, L., Mehrotra, A., Kausch, B., Trela, A., Tavassoli, M., Hoyte, E., O'Riordan, G., Blakemore, A., Seki, S., Hamilton, R. G., & Nadeau, K. C. (2014). Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 7. https://doi.org/10.1186/1710-1492-10-7
Bégin, Philippe, et al. "Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 10,1 (2014): 7. doi: https://doi.org/10.1186/1710-1492-10-7
Bégin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Tavassoli M, Hoyte E, O'Riordan G, Blakemore A, Seki S, Hamilton RG, Nadeau KC. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol. 2014 Feb 20;10(1):7. doi: 10.1186/1710-1492-10-7. PMID: 24576338; PMCID: PMC3936817.
Copy Download .nbib Format: NLM
The case for HER2/neu as a therapeutic target for gynecologic malignancies.

Immunotherapy

Goyne HE, Cannon MJ.
PMID: 22947006
Immunotherapy. 2012 Aug;4(8):781-4. doi: 10.2217/imt.12.71.

Evaluation of: Guzzo F, Bellone S, Buza N et al. HER2/neu as a potential target for immunotherapy in gynecological carcinosarcomas. Int. J. Gynecol. Pathol. 31, 211-221 (2012). Trastuzumab (Herceptin(®)) is a human monoclonal antibody that is US FDA-approved for...

Cite
Goyne HE, Cannon MJ. The case for HER2/neu as a therapeutic target for gynecologic malignancies. Immunotherapy. 2012;4(8):781-4doi: 10.2217/imt.12.71.
Goyne, H. E., & Cannon, M. J. (2012). The case for HER2/neu as a therapeutic target for gynecologic malignancies. Immunotherapy, 4(8), 781-4. https://doi.org/10.2217/imt.12.71
Goyne, Hannah E, and Cannon, Martin J. "The case for HER2/neu as a therapeutic target for gynecologic malignancies." Immunotherapy vol. 4,8 (2012): 781-4. doi: https://doi.org/10.2217/imt.12.71
Goyne HE, Cannon MJ. The case for HER2/neu as a therapeutic target for gynecologic malignancies. Immunotherapy. 2012 Aug;4(8):781-4. doi: 10.2217/imt.12.71. PMID: 22947006.
Copy Download .nbib Format: NLM
NITROUS OXIDE: HISTORY AND DEVELOPMENT.

British medical journal

Boyle HE.
PMID: 20778037
Br Med J. 1934 Jan 27;1(3812):153-5. doi: 10.1136/bmj.1.3812.153.

No abstract available.

Cite
Boyle HE. NITROUS OXIDE: HISTORY AND DEVELOPMENT. Br Med J. 1934;1(3812):153-5doi: 10.1136/bmj.1.3812.153.
Boyle, H. E. (1934). NITROUS OXIDE: HISTORY AND DEVELOPMENT. British medical journal, 1(3812), 153-5. https://doi.org/10.1136/bmj.1.3812.153
Boyle, H E. "NITROUS OXIDE: HISTORY AND DEVELOPMENT." British medical journal vol. 1,3812 (1934): 153-5. doi: https://doi.org/10.1136/bmj.1.3812.153
Boyle HE. NITROUS OXIDE: HISTORY AND DEVELOPMENT. Br Med J. 1934 Jan 27;1(3812):153-5. doi: 10.1136/bmj.1.3812.153. PMID: 20778037; PMCID: PMC2444118.
Copy Download .nbib Format: NLM
Successful use of daptomycin in Panton-Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis.

International journal of surgery case reports

Erturan G, Holme H, Smith R, Dodds R, Iyer S.
PMID: 22503914
Int J Surg Case Rep. 2012;3(7):238-41. doi: 10.1016/j.ijscr.2012.03.014. Epub 2012 Mar 23.

INTRODUCTION: Efficacy of daptomycin has been recorded in adult Gram-positive bone and joint infections OAI (1) and daptomycin has been used as secondary or tertiary agent when primary agents have failed (1, 2) in the treatment of osteoarticular infections...

Cite
Erturan G, Holme H, Smith R, et al. Successful use of daptomycin in Panton-Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis. Int J Surg Case Rep. 2012;3(7):238-41doi: 10.1016/j.ijscr.2012.03.014.
Erturan, G., Holme, H., Smith, R., Dodds, R., & Iyer, S. (2012). Successful use of daptomycin in Panton-Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis. International journal of surgery case reports, 3(7), 238-41. https://doi.org/10.1016/j.ijscr.2012.03.014
Erturan, Gurhan, et al. "Successful use of daptomycin in Panton-Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis." International journal of surgery case reports vol. 3,7 (2012): 238-41. doi: https://doi.org/10.1016/j.ijscr.2012.03.014
Erturan G, Holme H, Smith R, Dodds R, Iyer S. Successful use of daptomycin in Panton-Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis. Int J Surg Case Rep. 2012;3(7):238-41. doi: 10.1016/j.ijscr.2012.03.014. Epub 2012 Mar 23. PMID: 22503914; PMCID: PMC3356530.
Copy Download .nbib Format: NLM
Discussion on Posture in relation to General Anæsthesia.

Proceedings of the Royal Society of Medicine

Boyle HE.
PMID: 20902546
Proc R Soc Med. 1914;7:54.

No abstract available.

Cite
Boyle HE. Discussion on Posture in relation to General Anæsthesia. Proc R Soc Med. 1914;7:54
Boyle, H. E. (1914). Discussion on Posture in relation to General Anæsthesia. Proceedings of the Royal Society of Medicine, 754.
Boyle, H E. "Discussion on Posture in relation to General Anæsthesia." Proceedings of the Royal Society of Medicine vol. 7 (1914): 54.
Boyle HE. Discussion on Posture in relation to General Anæsthesia. Proc R Soc Med. 1914;7:54. PMID: 20902546.
Copy Download .nbib Format: NLM
Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes.

Geburtshilfe und Frauenheilkunde

Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, Fluhr H, Garnier Y, Grylka-Baeschlin S, Helmer H, Herting E, Hoopmann M, Hösli I, Hoyme U, Jendreizeck A, Krentel H, Kuon R, Lütje W, Mader S, Maul H, Mendling W, Mitschdörfer B, Nicin T, Nothacker M, Olbertz D, Rath W, Roll C, Schlembach D, Schleußner E, Schütz F, Seifert-Klauss V, Steppat S, Surbek D.
PMID: 31423017
Geburtshilfe Frauenheilkd. 2019 Aug;79(8):813-833. doi: 10.1055/a-0903-2735. Epub 2019 Aug 12.

No abstract available.

Cite
Berger R, Abele H, Bahlmann F, et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe Frauenheilkd. 2019;79(8):813-833doi: 10.1055/a-0903-2735.
Berger, R., Abele, H., Bahlmann, F., Bedei, I., Doubek, K., Felderhoff-Müser, U., Fluhr, H., Garnier, Y., Grylka-Baeschlin, S., Helmer, H., Herting, E., Hoopmann, M., Hösli, I., Hoyme, U., Jendreizeck, A., Krentel, H., Kuon, R., Lütje, W., Mader, S., Maul, H., Mendling, W., Mitschdörfer, B., Nicin, T., Nothacker, M., Olbertz, D., Rath, W., Roll, C., Schlembach, D., Schleußner, E., Schütz, F., Seifert-Klauss, V., Steppat, S., & Surbek, D. (2019). Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe und Frauenheilkunde, 79(8), 813-833. https://doi.org/10.1055/a-0903-2735
Berger, Richard, et al. "Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes." Geburtshilfe und Frauenheilkunde vol. 79,8 (2019): 813-833. doi: https://doi.org/10.1055/a-0903-2735
Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, Fluhr H, Garnier Y, Grylka-Baeschlin S, Helmer H, Herting E, Hoopmann M, Hösli I, Hoyme U, Jendreizeck A, Krentel H, Kuon R, Lütje W, Mader S, Maul H, Mendling W, Mitschdörfer B, Nicin T, Nothacker M, Olbertz D, Rath W, Roll C, Schlembach D, Schleußner E, Schütz F, Seifert-Klauss V, Steppat S, Surbek D. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Rupture of Membranes. Geburtshilfe Frauenheilkd. 2019 Aug;79(8):813-833. doi: 10.1055/a-0903-2735. Epub 2019 Aug 12. PMID: 31423017; PMCID: PMC6690742.
Copy Download .nbib Format: NLM
Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC.
PMID: 27222658
Allergy Asthma Clin Immunol. 2016 May 24;12:28. doi: 10.1186/s13223-016-0133-1. eCollection 2016.

[This corrects the article DOI: 10.1186/1710-1492-10-1.].

Cite
Bégin P, Winterroth LC, Dominguez T, et al. Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol. 2016;12:28doi: 10.1186/s13223-016-0133-1.
Bégin, P., Winterroth, L. C., Dominguez, T., Wilson, S. P., Bacal, L., Mehrotra, A., Kausch, B., Trela, A., Hoyte, E., O'Riordan, G., Seki, S., Blakemore, A., Woch, M., Hamilton, R. G., & Nadeau, K. C. (2016). Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 1228. https://doi.org/10.1186/s13223-016-0133-1
Bégin, Philippe, et al. "Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 12 (2016): 28. doi: https://doi.org/10.1186/s13223-016-0133-1
Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC. Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol. 2016 May 24;12:28. doi: 10.1186/s13223-016-0133-1. eCollection 2016. PMID: 27222658; PMCID: PMC4877751.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 94 entries